Effects of Baduanjin and PNF on Upper Crossed Syndrome Among University Students in Henan Province，China

Effects of Baduanjin and Proprioceptive Neuromuscular Facilitation on Upper Crossed Syndrome Among University Students in Henan Province，China

Upper crossed syndrome (UCS) is a condition threatening the physical health, anxiety level and quality of life of university students. Despite biomechanical and neurological approaches are available, evidence on their practicality and effectiveness remained scarce among university students. This randomized controlled trial aimed to determine the effectiveness of Baduanjin and Proprioceptive neuromuscular facilitation (PNF) on symptoms of UCS in university students in Henan Province, China. A total of 90 university students with crossed syndrome will be recruited and randomised into intervention (Baduanjin and PNF) and control groups. The intervention groups will undergo a structured exercise therapy or PNF for 12 weeks. The primary outcomes are improvement on neck range of motion and static posture while secondary outcomes are perceived Quality of Life (QoL) and level of anxiety.

Study Overview

• Status: Completed
• Conditions: Upper Crossed Syndorme
• Intervention / Treatment: Other: Baduanjin; Other: PNF

Detailed Description

In this study, the comparative design is referred to as a descriptive approach because of its appropriateness. This study was conducted primarily through an experimental intervention. It was a randomized controlled trial of 12 weeks duration. In this process, the research instruments and markers were prepared and then during the experiment, the comparative study was a descriptive comparative method, which was mainly described by comparing the changes in data before and after the experiment. This study includes three main aspects of the variable study. The first aspect was the range of motion of the neck joints, which consisted of six main variables: head extension, posterior extension, left extension, right extension, left rotation, and right rotation. The second aspect is the static postural index of patients with upper crossed syndrome. The FHA and FSA variables were selected for assessment in this study. The third aspect is the rating of patients' self-perceptions before and after the experiment, including the degree of cervical pain, the degree of cervical disability and the degree of anxiety. Also, these three aspects were the main measurements of the pre-test and post-test.

The specific process of this study was to first recruit subjects through WeChat and then screen them according to the UCS criteria set in this study. After screening, 90 university students with UCS were selected for random grouping. This experiment by different intervention methods can be divided into two experimental groups, Baduanjin group and PNF group, and a control group, that is, no intervention group. After the grouping, a pretest was administered to evaluate mainly from neck range of motion, static posture and self-perception. After the pre-test, each group received the experimental intervention treatment for 12 weeks. 12 weeks later a post-test was administered, which was consistent with the pre-test. The final data collected.

• Study Type: Interventional
• Enrollment (Actual): 90
• Phase: Not Applicable

Contacts and Locations

Study Locations

• China
  • Henan
    • Zhengzhou, Henan, China, 450000
      • Zhengzhou Normal University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• (1) FHA≥42°; (2) FSA≥49°; (3) Recurrent neck pain accompanied by dizziness and headache for ≥2 months; (4) Chest tightness, easy to panic, dyspnea. Severe cases with dizziness and headache; (5) The neck head is too long at the desk or the pain is aggravated after fatigue; (6) Tenderness and/or spasms in the neck and shoulder; (7) Neck and back muscles are tense and stiff, and neck motion is limited.

Exclusion Criteria:

• (1) Meet the above diagnostic criteria; (2) University students aged 18-23, male or female; (3) No other treatment and no other physical activities during the treatment; (4) Able to complete the whole rehabilitation program as planned; (5) Sign informed consent.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Baduanjin; This will be an experiment of about 60 minutes three times a week for 12 weeks.	Other: Baduanjin; 36 times.; Other: PNF; 36 times.
Experimental: PNF; This will be an experiment of about 60 minutes three times a week for 12 weeks.	Other: Baduanjin; 36 times.; Other: PNF; 36 times.
No Intervention: Control Group; The subjects performed daily activities for 12 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Static posture	Static postures are divided into Forward Head Angle and Forward Shoulder Angle.	12 weeks
Cervical range of motion (CROM)	Head forward, head back, head left, head right, head left rotation and head right rotation.	12 weeks
Pain	Numeric Pain Rating Scale (NPRS)	12 weeks
Neck disorder	Neck Disability Index	12 weeks
Anxiety	Self-rating Anxiety Scale	12 weeks
Quality of life	SF-12 scale	12 weeks

Collaborators and Investigators

• Sponsor: Universiti Putra Malaysia

Study record dates

Study Major Dates

• Study Start (Actual): October 9, 2024
• Primary Completion (Actual): October 15, 2024
• Study Completion (Actual): November 30, 2024

Study Registration Dates

• First Submitted: January 26, 2025
• First Submitted That Met QC Criteria: January 26, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: January 26, 2025
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Keywords: UCS
• Other Study ID Numbers: 20230067

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No